News & Events
< Back to News Overview
Heart failure experts appointed as Co-Principal Investigators for Sunshine Heart's
22 / 02 / 2007
Sunshine Heart (ASX: SHC) is pleased to announce that Dr William T Abraham of Ohio State University, Columbus, Ohio and Dr Patrick M McCarthy of Northwestern University,
Chicago, Illinois have agreed to become the Co-Principal Investigators for the C-PulseT Feasibility Trial in the United States.
The appointment of Drs Abraham and McCarthy continues Sunshine Heart's progress towards commencing the multi-centre US Feasibility Trial during 2007 following the positive meeting with the FDA (United States Food and Drug Administration) that was announced on 22 Dec 2006.
Chief Executive Officer of Sunshine Heart Donald Rohrbaugh said "The participation of Drs Abraham and McCarthy as Co-Principal Investigators with their combined experience in the management of heart failure and expertise as clinical investigators will add great credibility to the C-PulseT trial within the international medical community".
Dr Abraham who has participated in more than 100 drug and device clinical trials and has been International Principal or Co-Principal Investigator for several of Medtronic's heart failure pacemaker trials (Miracle, Miracle ICD) said "the C-PulseT has great potential in the treatment of patients with moderately severe heart failure".
William T Abraham, MD FACP, FACC, FAHA is Professor of Internal Medicine, Division Director of Cardiovascular Medicine and Deputy Director of the Davis Heart and Lung Research Institute at Ohio State University.
Patrick M McCarthy, MD is the Heller-Sacks Professor of Surgery, Division Chief of Cardiothoracic Surgery and Co-Director of the Bluhm Cardiovascular Institute of the Northwestern University Feinberg School of Medicine. Dr McCarthy has been recognised as an innovative and leading cardiovascular surgeon and researcher. He has been a clinical investigator in trials of several heart assist devices and is Chairman of the Society of Thoracic Surgeons/American Association for Thoracic Surgery Joint Working Group on New
Technology.
Dr McCarthy recently presented the C-PulseT at University's Heart Failure Summit, in "The Future of Congestive Heart Failure" Session.
Chicago, Illinois have agreed to become the Co-Principal Investigators for the C-PulseT Feasibility Trial in the United States.
The appointment of Drs Abraham and McCarthy continues Sunshine Heart's progress towards commencing the multi-centre US Feasibility Trial during 2007 following the positive meeting with the FDA (United States Food and Drug Administration) that was announced on 22 Dec 2006.
Chief Executive Officer of Sunshine Heart Donald Rohrbaugh said "The participation of Drs Abraham and McCarthy as Co-Principal Investigators with their combined experience in the management of heart failure and expertise as clinical investigators will add great credibility to the C-PulseT trial within the international medical community".
Dr Abraham who has participated in more than 100 drug and device clinical trials and has been International Principal or Co-Principal Investigator for several of Medtronic's heart failure pacemaker trials (Miracle, Miracle ICD) said "the C-PulseT has great potential in the treatment of patients with moderately severe heart failure".
William T Abraham, MD FACP, FACC, FAHA is Professor of Internal Medicine, Division Director of Cardiovascular Medicine and Deputy Director of the Davis Heart and Lung Research Institute at Ohio State University.
Patrick M McCarthy, MD is the Heller-Sacks Professor of Surgery, Division Chief of Cardiothoracic Surgery and Co-Director of the Bluhm Cardiovascular Institute of the Northwestern University Feinberg School of Medicine. Dr McCarthy has been recognised as an innovative and leading cardiovascular surgeon and researcher. He has been a clinical investigator in trials of several heart assist devices and is Chairman of the Society of Thoracic Surgeons/American Association for Thoracic Surgery Joint Working Group on New
Technology.
Dr McCarthy recently presented the C-PulseT at University's Heart Failure Summit, in "The Future of Congestive Heart Failure" Session.